The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs
COVID-19 is a highly contagious respiratory disease, which mainly affects the lungs. Critically ill patients are easily complicated by cytokine storms, acute respiratory distress syndrome (ARDS), and respiratory failure, which seriously threaten their lives. Pulmonary fibrosis (PF) is a common inter...
Saved in:
Main Authors: | Hao Shen (Author), Nu Zhang (Author), Yuqing Liu (Author), Xuerong Yang (Author), Yuanyuan He (Author), Qi Li (Author), Xiaoyan Shen (Author), Yulian Zhu (Author), Yong Yang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Individualized medication based on pharmacogenomics and treatment progress in children with IgAV nephritis
by: Xuerong Yang, et al.
Published: (2022) -
The Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics
by: Xirui Guo, et al.
Published: (2021) -
Endostatin in fibrosis and as a potential candidate of anti-fibrotic therapy
by: Zequn Zhang, et al.
Published: (2021) -
Macrophage‐based delivery of anti‐fibrotic proteins alleviates bleomycin‐induced pulmonary fibrosis in mice
by: Huiying Liu, et al.
Published: (2023) -
Carbapenem-resistant Gram-negative bacteria (CR-GNB) in ICUs: resistance genes, therapeutics, and prevention - a comprehensive review
by: Qi Li, et al.
Published: (2024)